Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow BAX
Baxter International Inc. (BAX) P/S ratio
As of 16 October 2026, Baxter International Inc. (BAX) trades at a P/S ratio of 1.1×. Over the past ten years it has ranged from 0.7× (March 2026) to 4.2× (February 2020); the current reading is higher than 9% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.9× | (37.64%) |
| FY2024 | 1.4× | (26.31%) |
| FY2023 | 1.9× | (25.82%) |
| FY2022 | 2.6× | (27.90%) |
| FY2021 | 3.5× | 1.40% |
| FY2020 | 3.5× | (6.60%) |
| FY2019 | 3.7× | 18.29% |
| FY2018 | 3.2× | (8.10%) |
| FY2017 | 3.4× | 44.34% |
| FY2016 | 2.4× | 14.04% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 1.0× | 25.74% |
| Mar 2026 | 0.8× | (12.34%) |
| Dec 2025 | 0.9× | (17.88%) |
| Sep 2025 | 1.1× | (25.58%) |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| BAX Baxter International Inc. | 1.1× |
| AVTR Avantor, Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 1.8× |
| ATR AptarGroup, Inc. compare | 2.0× |
| ALGN Align Technology, Inc. compare | 2.5× |
| COO The Cooper Companies, Inc. compare | 2.6× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| RGEN Repligen Corporation compare | 12.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on BAX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement